Blonder Tongue Laboratories, Inc.
BDRL
$0.0532
-$0.0068-11.33%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 112.80% | 39.03% | 0.09% | -24.49% | -361.19% |
| Total Depreciation and Amortization | -20.93% | -13.65% | -3.11% | -11.68% | 3.56% |
| Total Amortization of Deferred Charges | 0.00% | 3.33% | -3.23% | 6.90% | -6.45% |
| Total Other Non-Cash Items | 93.93% | 36.59% | 84.68% | -33.53% | 67.00% |
| Change in Net Operating Assets | -1,351.16% | 94.49% | -193.76% | 933.00% | 89.63% |
| Cash from Operations | 195.45% | 84.83% | -1,958.97% | 114.44% | 28.29% |
| Capital Expenditure | 27.78% | -20.00% | -650.00% | 89.47% | -375.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -150.00% | -- | -- |
| Cash from Investing | 27.78% | 10.00% | -400.00% | 78.95% | -375.00% |
| Total Debt Issued | -82.75% | -73.65% | -- | -- | -- |
| Total Debt Repaid | 0.56% | -275.37% | 185.29% | -435.21% | -82.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -15.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -747.73% | -97.44% | 823.11% | -142.35% | -17.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.64% | -177.29% | 253.05% | -5,566.67% | 104.11% |